Oculocerebrorenal syndrome of Lowe (OCRL) controls leukemic T-cell survival by preventing excessive PI(4,5)P2 hydrolysis in the plasma membrane.
暂无分享,去创建一个
V. Olkkonen | Mingchuan Li | Yuhui Tan | Daoguang Yan | Chaofeng Lai | Wenbin Zhong | Marion Weber-Boyvat | Huanzhao Chen | Mengyang Xu | Chen Lu | J. Zheng | Jie Xiao | Shuang Liu | Zhiquan Tang
[1] M. Garcia-Alloza,et al. Increased mitochondrial calcium levels associated with neuronal death in a mouse model of Alzheimer’s disease , 2020, Nature Communications.
[2] W. Lederer,et al. Regulation of Mitochondrial ATP Production: Ca2+ Signaling and Quality Control. , 2019, Trends in molecular medicine.
[3] V. Olkkonen,et al. ORP4L couples IP3 to ITPR1 in control of endoplasmic reticulum calcium release , 2019, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[4] Guowang Xu,et al. ORP4L Extracts and Presents PIP2 from Plasma Membrane for PLCβ3 Catalysis: Targeting It Eradicates Leukemia Stem Cells. , 2019, Cell reports.
[5] Jie J. Zheng,et al. OSBP-related protein 4L promotes phospholipase Cβ3 translocation from the nucleus to the plasma membrane in Jurkat T-cells , 2018, The Journal of Biological Chemistry.
[6] C. Erneux,et al. The impact of phosphoinositide 5-phosphatases on phosphoinositides in cell function and human disease , 2018, Journal of Lipid Research.
[7] N. Ridgway,et al. Bridging the molecular and biological functions of the oxysterol-binding protein family , 2018, Cellular and Molecular Life Sciences.
[8] Yang Sun,et al. Loss of OCRL increases ciliary PI(4,5)P2 in Lowe oculocerebrorenal syndrome , 2017, Journal of Cell Science.
[9] G. Hajnóczky,et al. Intracellular Ca2+ Sensing: Its Role in Calcium Homeostasis and Signaling. , 2017, Molecular cell.
[10] Guangju Ji,et al. ORP4L is essential for T-cell acute lymphoblastic leukemia cell survival , 2016, Nature Communications.
[11] A. Ballabio,et al. Autophagosome-lysosome fusion triggers a lysosomal response mediated by TLR9 and controlled by OCRL , 2016, Nature Cell Biology.
[12] Li-ping Zhu,et al. Raloxifene neutralizes the adverse effects of glutamate on cultured neurons by regulation of calcium oscillations. , 2015, Molecular medicine reports.
[13] B. Russell,et al. Actin dynamics is rapidly regulated by the PTEN and PIP2 signaling pathways leading to myocyte hypertrophy. , 2014, American journal of physiology. Heart and circulatory physiology.
[14] Marco Y. Hein,et al. A role of OCRL in clathrin-coated pit dynamics and uncoating revealed by studies of Lowe syndrome cells , 2014, eLife.
[15] M. Lowe,et al. The Cellular and Physiological Functions of the Lowe Syndrome Protein OCRL1 , 2014, Traffic.
[16] David Baker,et al. High-resolution comparative modeling with RosettaCM. , 2013, Structure.
[17] M. Marzolo,et al. OCRL controls trafficking through early endosomes via PtdIns4,5P2‐dependent regulation of endosomal actin , 2011, The EMBO journal.
[18] Hongling Ma,et al. OSBP-related protein 7 interacts with GATE-16 and negatively regulates GS28 protein stability. , 2011, Experimental cell research.
[19] R. Salomon,et al. From lowe syndrome to Dent disease: correlations between mutations of the OCRL1 gene and clinical and biochemical phenotypes , 2011, Human mutation.
[20] D. Vignali,et al. Organization of proximal signal initiation at the TCR:CD3 complex , 2009, Immunological reviews.
[21] M. Lowe,et al. Differential Clathrin Binding and Subcellular Localization of OCRL1 Splice Isoforms* , 2009, Journal of Biological Chemistry.
[22] C. Mitchell,et al. The role of the inositol polyphosphate 5-phosphatases in cellular function and human disease. , 2009, The Biochemical journal.
[23] M. Lowe,et al. Targeting of the type II inositol polyphosphate 5-phosphatase INPP5B to the early secretory pathway , 2007, Journal of Cell Science.
[24] P. De Camilli,et al. A role of the Lowe syndrome protein OCRL in early steps of the endocytic pathway. , 2007, Developmental cell.
[25] John Kuriyan,et al. Structural Basis for the Inhibition of Tyrosine Kinase Activity of ZAP-70 , 2007, Cell.
[26] T. Kerppola,et al. Design and implementation of bimolecular fluorescence complementation (BiFC) assays for the visualization of protein interactions in living cells , 2006, Nature Protocols.
[27] E. Eisenberg,et al. Lowe syndrome protein OCRL1 interacts with clathrin and regulates protein trafficking between endosomes and the trans-Golgi network. , 2005, Molecular biology of the cell.
[28] J. Lunardi,et al. Lowe syndrome protein Ocrl1 is translocated to membrane ruffles upon Rac GTPase activation: a new perspective on Lowe syndrome pathophysiology. , 2005, Human molecular genetics.
[29] P. Majerus,et al. The inositol polyphosphate 5-phosphatase Ocrl associates with endosomes that are partially coated with clathrin. , 2004, Proceedings of the National Academy of Sciences of the United States of America.
[30] J. Lunardi,et al. Lowe syndrome protein OCRL1 interacts with Rac GTPase in the trans-Golgi network. , 2003, Human molecular genetics.
[31] R. Foà,et al. Defective expression of the T‐cell receptor‐CD3 ζ chain in T‐cell acute lymphoblastic leukaemia , 2003, British journal of haematology.
[32] N. Ridgway,et al. Oxysterol-binding-protein (OSBP)-related protein 4 binds 25-hydroxycholesterol and interacts with vimentin intermediate filaments. , 2002, The Biochemical journal.
[33] R. Nussbaum,et al. Ocrl1, a PtdIns(4,5)P2 5-Phosphatase, Is Localized to the Trans-Golgi Network of Fibroblasts and Epithelial Cells , 2000, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.
[34] Péter Várnai,et al. Visualization of Phosphoinositides That Bind Pleckstrin Homology Domains: Calcium- and Agonist-induced Dynamic Changes and Relationship to Myo-[3H]inositol-labeled Phosphoinositide Pools , 1998, The Journal of cell biology.
[35] P. Majerus,et al. The protein deficient in Lowe syndrome is a phosphatidylinositol-4,5-bisphosphate 5-phosphatase. , 1995, Proceedings of the National Academy of Sciences of the United States of America.
[36] R. Nussbaum,et al. The Lowe's oculocerebrorenal syndrome gene encodes a protein highly homologous to inositol polyphosphate-5-phosphatase , 1992, Nature.
[37] S. Rhee,et al. CD3 stimulation causes phosphorylation of phospholipase C-gamma 1 on serine and tyrosine residues in a human T-cell line. , 1991, Proceedings of the National Academy of Sciences of the United States of America.
[38] Michael J. Berridge,et al. Inositol phosphates and cell signalling , 1989, Nature.
[39] E. Reinherz,et al. Most anti‐human CD3 monoclonal antibodies are directed to the CD3 ε subunit , 1989 .
[40] J. Foskett,et al. The mitochondrial Ca(2+) uniporter complex. , 2015, Journal of molecular and cellular cardiology.
[41] Oliver F. Lange,et al. Structure prediction for CASP8 with all‐atom refinement using Rosetta , 2009, Proteins.